Precision Biosciences DTIL
NASDAQ DTIL
$6.74 +0.03 (+0.45%)
As of: Oct 22, 2026 · 1:12 PM EDT

Precision Biosciences (DTIL) EV to CFO (2021)

Updated

Precision Biosciences' (DTIL) EV to CFO stood at 20881.60 in fiscal Q2 2021 (quarter ended Jun 30, 2021), up 683.7% from the prior quarter.

Analysis

Precision Biosciences (DTIL) EV to CFO (2021) Analysis & Trends

On a TTM basis, Precision Biosciences' EV to CFO came in at 20515.43 as of Jun 30, 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn
10 Precision Biosciences 174.27 Mn -174.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 20,881.60
Mar 31, 2021 2,664.36
API Access

Precision Biosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=DTIL&period=max&api_key=YOUR_API_KEY